INCYTE CORPORATION Operating Lease, Expense
INCYTE CORPORATION (INCY) reported Operating Lease, Expense of $2.90 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-08-04
- INCYTE CORPORATION operating lease, expense for the quarter ending 2020-06-30 was $2.90M, a 21.62% decline year-over-year.
- INCYTE CORPORATION operating lease, expense for the quarter ending 2020-03-31 was $3.50M, a 6.06% increase year-over-year.
- INCYTE CORPORATION operating lease, expense for the quarter ending 2019-06-30 was $3.70M, a 0.00% change year-over-year.
- INCYTE CORPORATION operating lease, expense for the quarter ending 2019-03-31 was $3.30M, a 0.00% change year-over-year.
- INCYTE CORPORATION operating lease, expense for fiscal 2019 was $14.20M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2020-06-30 | $2.90M 10-Q · filed 2020-08-04 | $6.40M 10-Q · filed 2020-08-04 | ||
| 2020-03-31 | $3.50M 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | $14.20M 10-K · filed 2020-02-13 | |||
| 2019-06-30 | $3.70M 10-Q · filed 2020-08-04 | $7.00M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $3.30M 10-Q · filed 2020-05-05 | |||
| 2018-09-30 | $3.60M 10-Q · filed 2019-10-29 | $7.30M derived: sum of 2 quarters · filed 2019-10-29 | $10.60M 10-Q · filed 2019-10-29 | |
| 2018-06-30 | $3.70M 10-Q · filed 2019-07-30 | $7.00M 10-Q · filed 2019-07-30 | ||
| 2018-03-31 | $3.30M 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |